Latest Acacia Pharma Stories
CAMBRIDGE, England, October 7, 2014 /PRNewswire/ -- Acacia Pharma announces positive Phase 3 results with APD421 for the management of post-operative nausea & vomiting
CAMBRIDGE, England, March 31, 2011 /PRNewswire/ -- - Funds to be Used to Complete Two Phase II Programmes Acacia Pharma, a pharmaceutical company specialising in the development of drugs for cancer supportive care, announces it has successfully closed a funding round, raising a total of $10 million.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.